The FDA should do more to establish a clear line between drug manufacturing and compounding, write Michael Carome and Sarah Sorscher of Public Citizen's Health Research Group in response to statements by FDA Commissioner Dr. Margaret Hamburg and agency official Howard Sklamberg. Compounders that act as manufacturers should be regulated as manufacturers, which is well within the FDA's authority, Sorscher and Carome write.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Showing posts with label FDA should put resources in better enforcement of compounding rules. Show all posts
Showing posts with label FDA should put resources in better enforcement of compounding rules. Show all posts
Subscribe to:
Posts (Atom)